GILD Competitors & Alternatives
Compare Gilead Sciences Inc with similar stocks in the same industry
Drug Manufacturers - General
GILD
Main Stock$152.21
Tradestie Score
35
Market Cap
$137.92B
Revenue Growth
0.1%
Analyst Upside
+4.2%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVO
Novo-Nordisk A/S
|
$38.71
|
$262.92B | 9.7 | 52 | Compare |
|
AZN
AstraZeneca PLC
|
$166.15
|
$261.56B | 24.8 | 55 | Compare |
|
NVS
Novartis AG
|
$146.88
|
$254.99B | 22.0 | 54 | Compare |
|
MRK
Merck & Co., Inc.
|
$148.69
|
$225.13B | 119.0 | 55 | Compare |
|
AMGN
Amgen Inc
|
$418.13
|
$160.70B | 25.8 | 56 | Compare |
|
PFE
Pfizer Inc.
|
$28.72
|
$154.70B | 37.7 | 47 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$41.18
|
$121.27B | 22.3 | 51 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$63.88
|
$96.54B | 13.8 | 58 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$49.70
|
$91.59B | 15.8 | 47 | Compare |
|
REGN
Regeneron Pharmaceuticals Inc
|
$752.25
|
$63.59B | 19.5 | 52 | Compare |
More GILD Analysis
Data updated: Sep 29, 2026 | Industry: Drug Manufacturers - General (SIC 2836)
17 stocks in this industry